Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis
- PMID: 18850512
- DOI: 10.1055/s-0028-1090585
Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis
Abstract
We compared the test characteristics of interleukin (IL)-1 beta, IL-6, IL-8, IL-10, IL-12(p-70), tumor necrosis factor-alpha (TNF-alpha), procalcitonin (PCT), C-reactive protein (CRP), and full blood count (FBC) in the diagnosis of neonatal sepsis. This prospective cohort study in the Neonatal Intensive Care Unit of Dunedin hospital of patients between July 1, 2002 and February 28, 2007 included 117 neonates commenced on antibiotics for 164 episodes of suspected sepsis. Blood cultures, FBC, CRP, IL-1 beta, IL-6, IL-8, IL-10, IL-12(p-70), TNF-alpha, and PCT were obtained at the time sepsis was first suspected and for the following 3 days. Receiver operator characteristics (ROC) plots and test characteristics were determined using culture-positive sepsis as the gold standard. At the time sepsis was first suspected, the most promising individual test was IL-12(p70) with an area under the curve (95% confidence interval [CI]) for the ROC of 0.74 (0.63 to 0.86), which (with a cutoff at 75 pg/mL) had a sensitivity (95% CI) of 28% (20 to 36%) and a specificity of 98% (96 to 100%). IL-10 had a sensitivity of 17% (10 to 23%) and a specificity of 99% (97 to 100%). IL-10 and IL-12(p70) are promising diagnostic tests that can be used to confirm sepsis in neonates.
Similar articles
-
Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.Turk J Pediatr. 2007 Jan-Mar;49(1):7-20. Turk J Pediatr. 2007. PMID: 17479639
-
Early and late markers for the detection of early-onset neonatal sepsis.Dan Med Bull. 2008 Nov;55(4):219-23. Dan Med Bull. 2008. PMID: 19232162
-
Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein.Intensive Care Med. 2004 Jul;30(7):1454-60. doi: 10.1007/s00134-004-2307-4. Epub 2004 May 4. Intensive Care Med. 2004. PMID: 15127192
-
[Evaluation of C reactive protein and others immunologic markers in the diagnosis of neonatal sepsis].Minerva Pediatr. 2007 Jun;59(3):267-74. Minerva Pediatr. 2007. PMID: 17519872 Review. Italian.
-
[C-reactive protein and cytokines in the diagnosis of neonatal sepsis].Med Pregl. 2006 Nov-Dec;59(11-12):545-9. doi: 10.2298/mpns0612545j. Med Pregl. 2006. PMID: 17633895 Review. Serbian.
Cited by
-
Neonatal infections in Saudi Arabia: Association with cytokine gene polymorphisms.Cent Eur J Immunol. 2015;40(1):68-77. doi: 10.5114/ceji.2015.50836. Epub 2015 Apr 22. Cent Eur J Immunol. 2015. PMID: 26155186 Free PMC article.
-
Plasma cytokine profiles in very preterm infants with late-onset sepsis.PLoS One. 2020 May 14;15(5):e0232933. doi: 10.1371/journal.pone.0232933. eCollection 2020. PLoS One. 2020. PMID: 32407417 Free PMC article.
-
Salivary and Serum Interleukin-10, C-Reactive Protein, Mean Platelet Volume, and CRP/MPV Ratio in the Diagnosis of Late-Onset Neonatal Sepsis in Full-Term Neonates.J Immunol Res. 2021 Oct 12;2021:4884537. doi: 10.1155/2021/4884537. eCollection 2021. J Immunol Res. 2021. PMID: 34676267 Free PMC article.
-
Biomarkers estimating baseline mortality risk for neonatal sepsis: nPERSEVERE: neonate-specific sepsis biomarker risk model.Pediatr Res. 2023 Oct;94(4):1451-1456. doi: 10.1038/s41390-022-02414-z. Epub 2022 Dec 13. Pediatr Res. 2023. PMID: 36513805 Free PMC article.
-
Diagnostics for neonatal sepsis: current approaches and future directions.Pediatr Res. 2017 Oct;82(4):574-583. doi: 10.1038/pr.2017.134. Epub 2017 Jun 28. Pediatr Res. 2017. PMID: 28574980 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous